LS Investment Advisors’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,237
Closed -$36K 1908
2017
Q3
$36K Hold
1,237
﹤0.01% 1461
2017
Q2
$32K Hold
1,237
﹤0.01% 1478
2017
Q1
$29K Hold
1,237
﹤0.01% 1490
2016
Q4
$31K Hold
1,237
﹤0.01% 1441
2016
Q3
$35K Hold
1,237
﹤0.01% 1351
2016
Q2
$31K Buy
1,237
+151
+14% +$3.75K ﹤0.01% 1379
2016
Q1
$24K Hold
1,086
﹤0.01% 1426
2015
Q4
$38K Hold
1,086
﹤0.01% 1265
2015
Q3
$31K Buy
1,086
+62
+6% +$2.08K ﹤0.01% 1338
2015
Q2
$34K Buy
+1,024
New +$31.4K ﹤0.01% 1347

LS Investment Advisors's PMC Position: Q4 2017 in Review

LS Investment Advisors sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 1,237 shares — an estimated $36K sold.

LS Investment Advisors first reported a position in PMC in Q2 2015 and held it in 10 quarters. The position peaked at $38K in Q4 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • LS Investment Advisors reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • LS Investment Advisors sold 1,237 PharMerica Corporation shares in Q4 2017, an estimated $36K.
  • LS Investment Advisors first reported a position in PharMerica Corporation in Q2 2015 and held it in 10 quarters.
  • LS Investment Advisors's PharMerica Corporation position peaked at $38K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on LS Investment Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.